Image source: Revista Galileu As Theranos’ case is advancing to a new phase in court, and after reading the very well researched book “Bad Blood: Secrets and Lies in a Silicon Valley Startup” from John Carreyrou, I think there are two lessons that could be helpful from the Latin America biotech standpoint. Reality Check As
Government Support For Innovation In Latin America.
Startups are constantly revitalizing the market, but they need a healthy environment to develop and be successful. Accelerators act in this context as a market-oriented agent, usually in the private sector using their financial investment capacity and have the function of directing and strengthening the development of startups. Over the last five years, Latin America started to grab the
Startup’s Scenario in Latin America for 2019
Private sector is catching up in Latam with an unprecedented rise of venture capital investment the region. 2018 was an absolute record year, mainly in Mexico, Colombia, Brazil, Argentina and Chile, and the trend continues in 2019. Unicorns are appearing in the scenario and strongly technology based, disruptive, innovative startups are attracting funds for expanding
4 Reasons Why Life Science Companies Need a Digital Transformation Agenda in Latin America
It is not new that customer purchase behavior was dramatically impacted by the advance of digital technologies, as buyers ourselves we can notice how retail has reshaped itself to accommodate our demands for fast and personalized services. However still some B2B leaders think this trend has small impact on short term to their business and